Diabeteszentrum Bad Lauterberg im Harz Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2009
NCT00683735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

liraglutide (victoza) (1 trial)

sitagliptin (januvia) (3 trials)

Drugs in Phase 1 Trials (1)

vildagliptin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3